Biogen (BIIB) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 248.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.93 | 52 Week High | $333.65 | |||
| Open | $248.93 | 52 Week Low | $223.02 | |||
| Day High | $248.93 | P/E | 31.87 | |||
| Day Low | $248.93 | EPS | $7.81 | |||
| Volume | 1,597 | |||||
